about
The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3-5 months.Blood-Brain Barrier in a Haemophilus influenzae Type a In Vitro Infection: Role of Adenosine Receptors A2A and A2B.RNA gene profile variation in peripheral blood mononuclear cells from rhesus macaques immunized with Hib conjugate vaccine, Hib capsular polysaccharide and TT carrier protein.A modular synthetic route to size-defined immunogenic Haemophilus influenzae b antigens is key to the identification of an octasaccharide lead vaccine candidate.Potential targets for next generation anti-microbial glycoconjugate vaccines.Rational Design and Evaluation of an Artificial Escherichia coli K1 Protein Vaccine Candidate Based on the Structure of OmpA.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hib Vaccines: Past, Present, and Future Perspectives
@ast
Hib Vaccines: Past, Present, and Future Perspectives
@en
Hib Vaccines: Past, Present, and Future Perspectives
@nl
type
label
Hib Vaccines: Past, Present, and Future Perspectives
@ast
Hib Vaccines: Past, Present, and Future Perspectives
@en
Hib Vaccines: Past, Present, and Future Perspectives
@nl
prefLabel
Hib Vaccines: Past, Present, and Future Perspectives
@ast
Hib Vaccines: Past, Present, and Future Perspectives
@en
Hib Vaccines: Past, Present, and Future Perspectives
@nl
P2860
P921
P356
P1476
Hib Vaccines: Past, Present, and Future Perspectives
@en
P2093
Hussein A Almehdar
P2860
P304
P356
10.1155/2016/7203587
P407
P5008
P577
2016-01-20T00:00:00Z